Gene array profile identifies collagen type XV as a novel human osteoblast-secreted matrix protein

Journal of Cellular Physiology

Volumn 220, Issue 2, 2009, Pages 401-409

  Lisignoli, Gina ^a   Codeluppi, Katia ^a   Todoerti, Katia ^b   Manferdini, Cristina ^a   Piacentini, Anna ^a   Zini, Nicoletta ^c   Grassi, Francesco ^a   Cattini, Luca ^a   Piva, Roberta ^d   Rizzoli, Vittorio ^e   Facchini, Andrea ^a,f   Giuliani, Nicola ^e   Neri, Antonino ^b,g  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

^e UNIVERSITY OF PARMA   (Italy)

^f UNIVERSITY OF BOLOGNA   (Italy)

^g UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHLORIDE; COLLAGEN TYPE 15; CALCIUM; COL15A1 PROTEIN, HUMAN; COLLAGEN;

AGED; APOPTOSIS; ARTICLE; BASEMENT MEMBRANE; BONE BIOPSY; BONE DEVELOPMENT; BONE MARROW CELL; BONE REMODELING; CELL DIFFERENTIATION; CELL ISOLATION; CELL LEVEL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EXTRACELLULAR CALCIUM; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SECRETION; STROMA CELL; UPREGULATION; ANIMAL; CELL CULTURE; CHEMISTRY; CYTOLOGY; EXTRACELLULAR MATRIX; GENETICS; METABOLISM; MICROARRAY ANALYSIS; MIDDLE AGED; PHYSIOLOGY;

AGED; ANIMALS; BONE MARROW CELLS; CALCIUM; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; HUMANS; MICROARRAY ANALYSIS; MIDDLE AGED; OSTEOBLASTS; OSTEOGENESIS; PHENOTYPE; STROMAL CELLS;

EID: 67649354589     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21779     Document Type: Article

References (64)

1. Agnelli L, Bicciato S, Mattioli M, Fabris S, Intini D, Verdelli D, Baldini L, Morabito F, Callea V, Lombardi L, Neri A. 2005. Molecular classification of multiple myeloma: A distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations. J Clin Oncol 23:7296-7306.
2. Amenta PS, Scivoletti NA, Newman MD, Sciancalepore JP, Li D, Myers JC. 2005. Proteoglycan-collagen XV in human tissues is seen linking banded collagen fibers subjacent to the basement membrane. J Histochem Cytochem 53:165-176.
3. Bielby R, Jones E, McGonagle D. 2007. The role of mesenchymal stem cells in maintenance and repair of bone. Injury 38:S26-S32.
4. Billiard J, Moran RA, Whitley MZ, Chatterjee-Kishore M, Gillis K, Brown EL, Komm BS, Bodine PV. 2003. Transcriptional profiling of human osteoblast differentiation. J Cell Biochem 89:389-400.
5. Birk DE, Bruckner P. 2005. Collagen suprastructures. Top Curr Chem 247:185-205.
6. Brummelkamp TR, Nijman SM, Dirac AM, Bernards R. 2003. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424:797-801.
7. Burkhardt R, Bartl R, Frisch B, Jäger K, Mahl C, Hill W, Kettner G. 1984. The structural relationship of bone forming and endothelial cells of the bone marrow. In: Arlet J, Ficat RP, Hungerford DS, editors. Bone circulation. Baltimore, MD: Williams and Wilkins. pp 2-14.
8. Caplan AI. 2005. Review: Mesenchymal stem cells: Cell-based reconstructive therapy in orthopedics. Tissue Eng 11:1198-1211.
9. Caplan AI. 2007. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213:341-347.
10. De Bari C, Dell'Accio F, Karystinou A, Guillot PV, Fisk NM, Jones EA,McGonagle D, Khan IM, Archer CW, Mitsiadis TA, Donaldson AN, Luyten FP, Pitzalis C. 2008. A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum 58:240-250.
11. Delorme B, Ringe J, Gallay N, Le Vern Y, Kerboeuf D, Jorgensen C, Rosset P, Sensebe L, Layrolle P, Haupl T, Charbord P. 2008. Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood 111:2631-2635.
12. Deng ZL, Sharff KA, Tang N, Song WX, Luo J, Luo X, Chen J, Bennett E, Reid R, Manning D, Xue A, Montag AG, Luu HH, Haydon RC, He TC. 2008. Regulation of osteogenic differentiation during skeletal development. Front Biosci 13:2001-2021.
13. Desai J, Shannon ME, Johnson MD, Ruff DW,Hughes LA, Kerley MK, Carpenter DA, Johnson DK, Rinchik EM, Culiat CT. 2006. Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects. Hum Mol Genet 15:1329-1341.
14. Di Cesare PE, Fang C, Leslie MP, Tulli H, Perris R, Carlson CS. 2000. Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblasts. J Orthop Res 18:713-720.
15. Ducy P, Schinke T, Karsenty G. 2000. The osteoblast:Asophisticated fibroblast under central surveillance. Science 289:1501-1504.
16. Durbin JE, Hackenmiller R, Simon MC, Levy DE. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84:443-450.
17. Dvorak MM, Siddiqua A, Ward DT, Carter DW, Dallas SL, Nemeth EF, Riccardi D. 2004. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci 101:5140-5145.
18. Eriksen EF, Eghbali-Fatourechi GZ, Khosla S. 2007. Remodeling and vascular spaces in bone. J Bone Miner Res 22:1-6.
19. Hagg PM, Hagg PO, Peltonen S, utio-Harmainen H, Pihlajaniemi T. 1997. Location of type XV collagen in human tissues and its accumulation in the interstitial matrix of the fibrotic kidney. Am J Pathol 150:2075-2086.
20. Harada S, Rodan GA. 2003. Control of osteoblast function and regulation of bone mass. Nature 423:349-355.
21. Harper J, Gerstenfeld LC, Klagsbrun M. 2001. Neuropilin-1 expression in osteogenic cells: Down-regulation during differentiation of osteoblasts into osteocytes. J Cell Biochem 81:82-92.
22. Harris A, Harris H, Hollingsworth MA. 2007. Complete suppression of tumor formation by high levels of basement membrane collagen. Mol Cancer Res 5:1241-1245.
23. Hauge EM, Qvesel D, Eriksen EF, Mosekilde L, Melsen F. 2001. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res 16:1575-1582.
24. Hering S, Isken E, Knabbe C, Janott J, Jost C, Pommer A, Muhr G, Schatz H, Pfeiffer AF. 2001. TGFbeta1 and TGFbeta2 mRNA and protein expression in human bone samples. Exp Clin Endocrinol Diabetes 109:217-226.
25. Hsieh SH, Ying NW, Wu MH, Chiang WF, Hsu CL, Wong TY, Jin YT, Hong TM, Chen YL. 2008. Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene 27:3746-3753.
26. Ishii M, Koike C, Igarashi A, Yamanaka K, Pan H, Higashi Y, Kawaguchi H, Sugiyama M, Kamata N, Iwata T, Matsubara T, Nakamura K, Kurihara H, Tsuji K, Kato Y. 2005. Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblasts. Biochem Biophys Res Commun 332:297-303.
27. Kietty CM, Grant ME. 2002. The collagen family: Structure, assembly, and organization in the extracellular matrix. In: Royce PM, Sheinmann B, editors. Connective tissue and its heritable disorders. New York: Wiley-Liss, Inc. pp 159-221.
28. Kulterer B, Friedl G, Jandrositz A, Sanchez-Cabo F, Prokesch A, Paar C, Scheideler M, Windhager R, Preisegger KH, Trajanoski Z. 2007. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics 8:70.
29. Li D, Clark CC, Myers JC. 2000. Basement membrane zone type XV collagen is a disulfidebonded chondroitin sulfate proteoglycan in human tissues and cultured cells. J Biol Chem 275:22339-22347.
30. Lisignoli G, Toneguzzi S, Grassi F, Piacentini A, Tschon M, Cristino S, Gualtieri G, Facchini A. 2002. Different chemokines are expressed in human arthritic bone biopsies: IFN-gamma and IL-6 differently modulate IL-8, MCP-1 and RANTES production by arthritic osteoblasts. Cytokine 20:231-238.
31. Lisignoli G, Cristino S, Piacentini A, Toneguzzi S, Grassi F, Cavallo C, Zini N, Solimando L, Maraldi NM, Facchini A. 2005. Cellular and molecular events during chondrogenesis of humanmesenchymal stromal cells grown in a three-dimensional hyaluronan based scaffold. Biomaterials 26:5677-5686.
32. Lisignoli G, Piacentini A, Cristino S, Grassi F, Cavallo C, Cattini L, Tonnarelli B, Manferdini C, Facchini A. 2007. CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: Increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients. J Cell Physiol 210:798-806.
33. Maraldi NM, Zini N, Ognibene A, Martelli AM, Barbieri M, Mazzotti G, Manzoli FA. 1995. Immunocytochemical detection of the intranuclear variations of phosphatidylinositol 4,5-bisphosphate amount associated with changes of activity and amount of phospholipase C beta 1 in cells exposed to mitogenic or differentiating agonists. Biol Cell 83:201-210.
34. Mattioli M, Agnelli L, Fabris S, Baldini L, Morabito F, Bicciato S, Verdelli D, Intini D, Nobili L, Cro L, Pruneri G, Callea V, Stelitano C, Maiolo AT, Lombardi L, Neri A. 2005. Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma. Oncogene 24:2461-2473.
35. McKee MD, Addison WN, Kaartinen MT. 2005. Hierarchies of extracellular matrix and mineral organization in bone of the craniofacial complex and skeleton. Cells Tissues Organs 181:176-188.
36. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431-442.
37. Muona A, Eklund L, Vaisanen T, Pihlajaniemi T. 2002. Developmentally regulated expression of type XV collagen correlates with abnormalities in Col15a1(-/-) mice. Matrix Biol 21:89-102.
38. Myers JC, Li D, Bageris A, Abraham V, Dion AS, Amenta PS. 1997. Biochemical and immunohistochemical characterization of human type XIX defines a novel class of basement membrane zone collagens. Am J Pathol 151:1729-1740.
39. Myers JC, Amenta PS, Dion AS, Sciancalepore JP, Nagaswami C, Weisel JW, Yurchenco PD. 2007. The molecular structure of human tissue type XV presents a unique conformation among the collagens. Biochem J 404:535-544.
40. Nauta AJ, Fibbe WE. 2007. Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506.
41. Parfitt AM. 2001. The bone remodeling compartment: A circulatory function for bone lining cells. J Bone Miner Res 16:1583-1585.
42. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
43. Pountos I, Corscadden D, Emery P, Giannoudis PV. 2007. Mesenchymal stem cell tissue engineering: Techniques for isolation, expansion and application. Injury 38:S23-S33.
44. Robey PG, Termine JD. 1985. Human bone cells in vitro. Calcif Tissue Int 37:453-460.
45. Rozen S, Skaletsky H. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365-386.
46. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M, Bianco P. 2007. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131:324-336.
47. Sakaguchi Y, Sekiya I, Yagishita K, Ichinose S, Shinomiya K, Muneta T. 2004. Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates. Blood 104:2728-2735.
48. Salasznyk RM, Westcott AM, Klees RF,Ward DF, Xiang Z, Vandenberg S, Bennett K, Plopper GE. 2005. Comparing the protein expression profiles of human mesenchymal stem cells and human osteoblasts using gene ontologies. Stem Cells Dev 14:354-366.
49. Schadt EE, Li C, Ellis B, Wong WH. 2001. Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. J Cell Biochem Suppl 37:120-125.
50. Silva WA, Jr., Covas DT, Panepucci RA, Proto-Siqueira R, Siufi JL, Zanette DL, Santos AR, Zago MA. 2003. The profile of gene expression of humanmarrow mesenchymal stem cells. Stem Cells 21:661-669.
51. Stegmeier F, Sowa ME, Nalepa G, Gygi SP,Harper JW, Elledge SJ. 2007. The tumor suppressor CYLD regulates entry into mitosis. Proc Natl Acad Sci USA 104:8869-8874.
52. Teitelbaum SL. 2006. Osteoclasts and integrins. Ann NY Acad Sci 1068:95-99.
53. Teitelbaum SL, Ross FP. 2003. Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638-649.
54. Tian Y, Deng YB, Huang YJ, Wang Y. 2008. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation. Immunol Invest 37:29-42.
55. Tomono Y, Naito I, Ando K, Yonezawa T, Sado Y,Hirakawa S,Arata J, Okigaki T,Ninomiya Y. 2002. Epitope-defined monoclonal antibodies against multiplexin collagens demonstrate that type XV and XVIII collagens are expressed in specialized basement membranes. Cell Struct Funct 27:9-20.
56. Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G. 2003.CYLD is a deubiquitinating enzyme that negatively regulatesNF-kappaB activation by TNFR family members. Nature 424:793-796.
57. Tuli R, Tuli S, Nandi S, Wang ML, Alexander PG, Haleem-Smith H, Hozack WJ, Manner PA, Danielson KG, Tuan RS. 2003. Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells 21:681-693.
58. Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121.
59. Wagner W, Roderburg C, Wein F, Diehlmann A, Frankhauser M, Schubert R, Eckstein V, Ho AD. 2007. Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem Cells 25:2638-2647.
60. Wang Z, Goh J, Das DS, Ge Z, Ouyang H, Chong JS, Low SL, Lee EH. 2006. Efficacy of bone marrow-derived stem cells in strengthening osteoporotic bone in a rabbit model. Tissue Eng 12:1753-1761.
61. Widemann A, Sabatier F, Arnaud L, Bonello L, Al-Massarani G, Paganelli F, Poncelet P, gnat-George F. 2008. CD146-based immunomagnetic enrichment followed by multi-parameter flow cytometry: A new approach to count circulating endothelial cells. J Thromb Haemost 6:869-876.
62. Xiao L, Naganawa T, Obugunde E, Gronowicz G, Ornitz DM, Coffin JD, Hurley MM. 2004. Stat1 controls postnatal bone formation by regulating fibroblast growth factor signaling in osteoblasts. J Biol Chem 279:27743-27752.
63. Yin T, Li L. 2006. The stem cell niches in bone. J Clin Invest 116:1195-1201.
64. Zini N, Martelli AM, Cocco L, Manzoli FA, Maraldi NM. 1993. Phosphoinositidase C isoforms are specifically localized in the nuclear matrix and cytoskeleton of Swiss 3T3 cells. Exp Cell Res 208:257-269.